DelMar Pharmaceuticals, Inc. and Guangxi Wuzhou

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DelMar Pharmaceuticals, Inc. and Guangxi Wuzhou Pharmaceutical Company Announce Chinese Government Funding Award

VANCOUVER, BC and MENLO PARK, CA--(Marketwired - Jul 8, 2013) - DelMar Pharmaceuticals, Inc. ( OTCQB : DMPI ) ("DelMar Pharma") today announced that the Chinese Bureau of Foreign Experts has approved the application for a grant to Guangxi Wuzhou Pharmaceutical Company to support DelMar Pharma's collaboration with Guangxi Wuzhou Pharmaceutical Company, a subsidiary of publicly traded Guangxi Wuzhou Zhongheng Group Co., Ltd (SHG 600252).

In October 2012, DelMar and Guangxi Wuzhou Pharmaceuticals announced a collaboration for the development of VAL-083, known as "DAG for Injection" in China.

The collaboration between DelMar and Guangxi Wuzhou Pharmaceuticals includes development and an exclusive supply relationship of VAL-083 for the Chinese market and all markets outside China. Wuzhou Pharmaceuticals is the exclusive supplier of VAL-083 and DelMar Pharma is responsible for development and commercialization. 

As part of the collaboration, DelMar Pharma and Guangxi Wuzhou Pharmaceuticals are working together to insure the product specifications meet global standards in order to accelerate international development and to enable Guangxi Wuzhou Pharmaceuticals to obtain certification as manufacturer of VAL-083 from international regulatory authorities including the U.S. Food and Drug Administration. Funding from the grant, which will be paid by Chinese Bureau of Foreign Experts, will directly offset a portion of DelMar Pharma's expenditures related to the project.

Jeffrey Bacha, President & CEO of DelMar Pharma said, "We are pleased to have the financial support and recognition of this important collaboration."

VAL-083 represents a 'first-in-class' small-molecule chemotherapeutic. VAL-083 has been assessed in multiple NCI-sponsored clinical studies in various cancers including lung, brain, cervical, ovarian tumors and leukemia. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types. 

VAL-083 is approved as a cancer chemotherapeutic in China for the treatment of chronic myelogenous leukemia and lung cancer. In addition, DelMar is conducting a Phase I/II clinical trial to assess the safety and efficacy of VAL-083 in refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. 

About Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. and Zhongheng Group Co. Ltd.

Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd., a wholly owned subsidiary of Zhongheng Group Co., Ltd. (SHG 600252) is principally engaged in the manufacture of pharmaceuticals. The Company's main products include cardiovascular drugs, medicine for bruises, and gynecology medication, among others. Zhongheng Group is also involved in the investment and management of infrastructure and logistics services, asset operation and management, as well as domestic and international commercial trading. In addition, the Company is involved in the manufacture and distribution of Chinese herbal jelly products. The Company operates its businesses in various regions in China. Further information is available on the companies website: http://www.wz-zhongheng.com/

About DelMar Pharma DelMar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 benefits from extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action.

Safe Harbor Statement Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K. We do not undertake to update these forward-looking statements made by us.

For further information, please visit www.delmarpharma.com ; or contact Jeffrey A. Bacha, President & CEO (604) 629-5989 or Booke & Company Investor Relations, admin@bookeandco.com

For further information, please visit www.delmarpharma.com or contact Jeffrey A. Bacha President & CEO (604) 629-5989 or Booke & Company Investor Relations admin@bookeandco.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 489

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 114

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 775

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 94

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 106

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 130

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 221

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 292

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
CommBank Yello Builds a Wider Moat Around Customers

Updated Category News Views 23

Nine million customers is not a pilot program; it is a crowded stadium, and CommBank has decided to hand everyone a reason to stay in their seats. Commonwealth Bank's expanded CommBank Yello program now lets eligible customers earn points across home loans, term deposits, cards and insurance, then redeem with well-known brands. That is a serious attempt to make a bank...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Global Voices: WAC conference speaker lineup

Updated Category News Views 322

Premier Speakers Set to Inspire at the World Affairs Conference Excitement continues to build for the upcoming World Affairs Conference (WAC), attracting attention from students and educators alike. This prestigious event promises a day filled with thought-provoking discussions and insights from renowned speakers, including Bill Weir, Keith Pelley, and Dr. James Orbinski....

Continue Reading
Transform Your Investment Journey With Westinghouse Air Brake

Updated Category News Views 166

Long-Term Growth of Westinghouse Air Brake Understanding the remarkable growth of Westinghouse Air Brake is essential for current and prospective investors. Over the elapsed two decades, this company has consistently outperformed the market, achieving an impressive annualized growth rate of 14.54%. Cumulative Return on Investment If one had invested $100 in Westinghouse...

Continue Reading
Revitalizing Healthcare: Bipartisan Efforts to Combat Sepsis

Updated Category News Views 179

Revitalizing Healthcare Efforts with the SEPSIS Act In a significant move to address one of the most critical health challenges facing the nation today, the SEPSIS Act has been reintroduced in the Senate. This bipartisan legislation aims to tackle the sepsis crisis—a pressing issue that affects countless families and places a heavy burden on healthcare resources. With a...

Continue Reading
Transforming Innovation: The Charles Huang Initiative in Glasgow

Updated Category News Views 256

Revitalizing Education and Innovation The Charles Huang Foundation (CHF) has announced a transformative project at the University of Strathclyde, aiming to bolster educational and entrepreneurial efforts through a £30 million investment. This funding will be pivotal in converting a former Student Union building on John Street into the Charles Huang Advanced Technology &...

Continue Reading
Ally Waste Chosen for Valet Trash Services by RangeWater Real Estate

Updated Category News Views 190

Ally Waste Partners with RangeWater Real Estate for Waste Solutions Ally Waste, a prominent provider of valet trash services and various onsite waste solutions for multifamily communities, has been selected as the preferred valet trash service provider for RangeWater Real Estate. This decision comes after a meticulous evaluation of potential service partners through a...

Continue Reading